The National Cancer Institute leads the National Cancer Program and the NIH's efforts to dramatically reduce the prevalence of cancer and improve the lives of cancer patients and their families, through research into prevention and cancer biology, the dev
Susan Vadaparampil, Ph.D., M.P.H.Assistant ProfessorH. Lee Moffitt Cancer Center & Research Institute
Dr. Susan Vadaparampil received a her bachelor's and master's degrees in Health Science Education from the University of Florida, an M.P.H. from Johns Hopkins University with an emphasis in Epidemiology, and a Ph.D. in Health Behavior from Indiana University in 2000.She then completed a postdoctoral fellowship in Cancer Prevention at the National Cancer Institute.
Dr. Vadaparampil is currently an Assistant Professor in the Department of Interdisciplinary Oncology at the University of South Florida College of Medicine and a Member-In-Residence in the Health Outcomes and Behavior Program at H. Lee Moffitt Cancer Center.She currently holds an adjunct faculty appointment at the University of South Florida College of Public Health and is an Adjunct Scientist in the Clinical Genetics Branch at the National Cancer Institute.Her research interests focus on awareness, knowledge, and use of genetic testing for inherited cancer susceptibility in the general population, minority groups, physicians and at-risk populations.
In order to further develop these interests, she has successfully obtained peer-reviewed extramural funding from several national agencies.
In January 2006, Dr. Vadaparampil was awarded a five-year American Cancer Society Mentored Research Scholar Grant to explore the impact of genetic counseling on recently diagnosed breast cancer patients.
The specific aims of the study are to examine: factors that predict whether a woman receives genetic counseling during or after she begins her definitive breast cancer treatment; patient satisfaction with BRCA1/2 genetic counseling; and the impact of BRCA1/2 genetic counseling in reducing decisional conflict about proceeding with BRCA1/2 genetic testing.
With the information obtained from the present study, Dr. Vadaparampil will develop interventions designed to optimize the timing, content, and process of BRCA1/2 counseling and testing for breast cancer patients.
In addition, Dr. Vadaparampil also obtained an R03 Grant from the National Human Genome Research Institute.
The specific aims of this study are to apply Social Marketing theory to: examine knowledge, attitudes, and behaviors related to cancer genetics among Mexican, Puerto Rican, and Cuban women at increased risk for hereditary breast and ovarian cancer (HBOC); develop a series of culturally relevant messages related to HBOC and genetic counseling and testing specific to Mexican, Puerto Rican, and Cuban American women at increased risk for HBOC; and identify appropriate dissemination channels for these messages.
Study findings will serve as the basis for a larger intervention trial based in a public health department setting to educate Hispanic women at increased risk for HBOC about genetic counseling and testing for HBOC that will apply the final three phases of Social Marketing including: pretesting, implementation, and evaluation of the messages.
Dr. Vadaparampil also serves as a collaborator/co-investigator on several cancer prevention and control studies in the areas of physician knowledge and use of genetic testing for inherited cancer susceptibility, establishing the prevalence of BRCA1/2 mutations in the African American population, psychosocial aspects of familial testicular cancer, health care provider discussion of fertility preservation among pediatric and young adult cancer patients and their families, and the psychosocial impact of HPV on men.
Study Team - Breast Cancer Genetics Research & Education for African American Women
Susan Vadaparampil is a behavioral scientist with an interest in uptake and outcomes related to genetic counseling and testing for hereditary breast cancer in minority communities.Her research program focuses on increasing awareness, knowledge, and risk appropriate utilization of genetics services among patients and health care providers.
She is a co-investigator of the BEST Study and Co-Directs the B-GREAT Initiative alongside Dr. Pal.
Hematology-Oncology | JCOM | Journal of Clinical Outcomes Management | Turner White
Susan T. Vadaparampil, PhD, MPH, Joanne Kelvin, MSN, RN, Devin Murphy, MSW, Meghan Bowman, Ivana Sehovic, MPH, and Gwendolyn P. Quinn, PhD, Med
Corresponding author: Susan T. Vadaparampil, PhD, MPH, 12902 Magnolia Dr., MRC CANCONT, Tampa, FL 33612, firstname.lastname@example.org.
Funding/support: ENRICH is funded by a National Cancer Institute R25 Training Grant: #5R25CA142519-05.
Thank You for Downloading!
1. Download ZoomInfo Grow
2. Run Installation Wizard
3. Check your inbox to Sign in to ZoomInfo Grow